Su, Xi |
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) |
|
|
| Active, not recruiting | N/A | 539 | RoW | BuMA Supreme, BuMA™ | Sino Medical Sciences Technology Inc. | Coronary Artery Disease | 03/18 | 12/25 | | |
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) |
|
|
| Active, not recruiting | N/A | 1000 | RoW | BuMA Supreme | Sino Medical Sciences Technology Inc. | Coronary Artery Disease | 05/19 | 12/25 | | |
NCT04569669: The Sensitivity and Specificity of CardioSimFFRct Analysis Software on Coronary Artery Stenosis |
|
|
| Not yet recruiting | N/A | 325 | RoW | FFR and FFRCT | CCRF Inc., Beijing, China, Shengshi Technology, Co., Ltd, Hangzhou, China | Coronary Stenosis | 10/21 | 03/22 | | |
SIBLINT ISR, NCT04240444: Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis |
|
|
| Completed | N/A | 260 | RoW | drug-coated balloon Catheter | B. Braun Medical International Trading Company Ltd., CCRF Inc., Beijing, China | Coronary Artery Disease, In Stent Restenosis | 07/22 | 08/22 | | |
| Not yet recruiting | N/A | 220 | RoW | Paclitaxel-Eluting Coronary Balloon Dilation Catheter (DIOR), Paclitaxel-Eluting Balloon (Bingo) | CCRF Inc., Beijing, China | Percutaneous Coronary Intervention | 05/22 | 10/22 | | |
COOPERATION, NCT04912518: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction |
|
|
| Recruiting | N/A | 250 | RoW | Dexmedetomidine (DEX), Placebo (Saline) | Harbin Medical University, Yangtze River Pharmaceutical Group Co., Ltd. | ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection | 12/24 | 12/25 | | |
NCT05375110: NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure) |
|
|
| Recruiting | N/A | 120 | RoW | NoYAâ„¢ Radiofrequency Interatrial Shunt System | Hangzhou NOYA MedTech Co. Ltm. | Heart Failure | 12/22 | 12/23 | | |
Yan, Hua |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
| Not yet recruiting | 3 | 8862 | RoW | Colchicine 0.5 mg, no other name, Colchicine 0.375 mg, Placebo | Wuhan Union Hospital, China | Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine | 03/28 | 08/28 | | |
NCT06458595: Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) |
|
|
| Recruiting | 1/2 | 44 | RoW | KH658 | Chengdu Origen Biotechnology Co., Ltd. | Age-related Macular Degeneration | 03/26 | 12/26 | | |
| Terminated | N/A | 51 | RoW | Spectral CT | Philips (China) Investment CO., LTD, Shanghai Changzheng Hospital, Ruijin Hospital, West China Hospital | CT Scanning | 11/22 | 02/23 | | |
NCT05396209: To Evaluate the Therapeutic Efficacy of Hydrated Amniotic Membrane in Promoting Closure of Refractory Macular Holes. |
|
|
| Recruiting | N/A | 80 | RoW | Hydrated Amniotic Membrane Plug, ILM filling, Conventional ILM peeling | Oriental Neurosurgery Evidence-Based-Study Team | Macular Holes | 05/24 | 06/25 | | |
| Not yet recruiting | N/A | 500 | RoW | Assessment of plaque morphology, structure, and stability in non-culprit lesions | Chinese PLA General Hospital | Coronary Arterial Disease (CAD), Acute Coronary Syndromes | 12/27 | 12/31 | | |
NCT04212494: Thrombus Aspiration in STEMI Patients With High Thrombus Burden |
|
|
| Recruiting | N/A | 3838 | RoW | Thrombus aspiration, PCI Alone | Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital | ST-segment Elevation Myocardial Infarction (STEMI) | 08/25 | 02/26 | | |
qiu, Qiu |
NCT04988828: The Effects of Whole-body Vibration on Increasing Quadriceps Strength in Patients With ACL Ruptures |
|
|
| Recruiting | N/A | 100 | RoW | Whole body vibration | Chinese University of Hong Kong | Anterior Cruciate Ligament Injuries, Quadriceps Muscle Atrophy | 07/22 | 09/22 | | |
CHD-PAHCS, NCT03977428: Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study |
|
|
| Recruiting | N/A | 500 | RoW | standard of care | Wuhan Asia Heart Hospital | Pulmonary Arterial Hypertension | 12/22 | 06/23 | | |
| Recruiting | N/A | 500 | RoW | | Wuhan Asia Heart Hospital | Pulmonary Arterial Hypertension | 12/23 | 12/25 | | |
| Recruiting | N/A | 7000 | RoW | | Guangzhou Women and Children's Medical Center | Gestational Diabetes Mellitus, Pregnancy Outcome, Neurodevelopment, Immune Development, Childhood Obesity, Host and Microbiome | 12/38 | 12/38 | | |
gangcheng, Zhang |
| Recruiting | 3 | 440 | RoW | PFO closure device, Aspirin and clopidogrel, Triptans | Guangdong Provincial People's Hospital | PFO - Patent Foramen Ovale, Migraine | 07/24 | 07/25 | | |
CHD-PAHCS, NCT03977428: Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study |
|
|
| Recruiting | N/A | 500 | RoW | standard of care | Wuhan Asia Heart Hospital | Pulmonary Arterial Hypertension | 12/22 | 06/23 | | |